CMS continues to offer flexibilities to provide relief to clinicians responding to the COVID-19 public health emergency (PHE). CMS applied the Merit-based Incentive Payment System (MIPS) automatic extreme and uncontrollable circumstances (EUC)...
The Centers for Medicare & Medicaid Services (CMS) continues to offer flexibilities to provide relief to clinicians responding to the COVID-19 public health emergency (PHE). CMS applied the Merit-based Incentive Payment System (MIPS) automatic...
The Centers for Medicare & Medicaid Services (CMS) added new Quality Payment Program (QPP) performance information for doctors, clinicians, groups, and Accountable Care Organizations (ACOs) to the Doctors and Clinicians section of Medicare Care...
As part of its renewed vision and strategy for driving health system transformation (PDF) , the Center for Medicare and Medicaid Innovation (CMS Innovation Center) is releasing a Request for Applications (RFA) for the Accountable Care Organization (...
On February 11, the Food and Drug Administration (FDA) authorized the emergency use of the monoclonal antibody bebtelovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients when all of these apply: They have a positive...
The Centers for Medicare & Medicaid Services (CMS) has posted new resources related to MIPS Value Pathways (MVPs) development on the QPP Resource Library . The following documents are now available in the MIPS Value Pathways (MVPs) Development...
As a reminder, the Centers for Medicare & Medicaid Services (CMS) and its contractor, Acumen, LLC, are conducting field testing of five episode-based cost measures until February 25 . The following episode-based cost measures are currently being...
The Centers for Medicare & Medicaid Services (CMS) is now posting data on COVID-19 vaccine booster shots administered to nursing home residents and staff on the Medicare.gov Care Compare website . The data will show resident and staff booster...
On December 28, the FDA revised the emergency use authorization for COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies. It’s authorized for treatment of COVID-19 in patients with immunosuppressive disease or getting...
The January 2022 refresh of Skilled Nursing Facility (SNF) Quality Reporting Program data is available on the Care Compare webpage and in the Provider Data Catalog . Visit the SNF Quality Public Reporting webpage for more information.
